On ECHEMI
Home > Drugs > Shandong XinYi Pharmaceutical Co., Ltd.
Shandong XinYi Pharmaceutical Co., Ltd.
  • Founded in:

    2013-04-09
  • Country:

    China China
  • Address:

    No. 1 Xingping Road, Pingyuan County
  • Tax NO.:

    91371426065926234K
  • Registered Funds:

    177.40615851 million yuan
  • Website:

  • Email:

Related Drugs
Dioxin Hydrochloride
Name Description Content CAS NO. Registered Holders
DIOXOPROMETHAZINE HCL

Extract from the above information

More

Extract from the above information

13754-56-8 6
Amiodarone Hydrochloride Tablets
(2-Butyl-3-benzofuranyl)[4-[2-(diethylamino)ethoxy[-3,5-diiodophenyl]methanone hydrochloride.
Name Description Content CAS NO. Registered Holders
Amiodarone hydrochloride

This product belongs to Class III antiarrhythmic drugs. The main electrophysiological effect is to prolong the action potential and effective refractory period of various myocardial tissues, which is conducive to eliminating reentrant excitation. At the same time, it has mild non-competitive α and β adrenergic receptor blocking and mild Class I and IV antiarrhythmic properties. Reduce the automaticity of the sinus node. It has no effect on the resting membrane potential and action potential height. The inhibition of forward conduction of the atrioventricular bypass pathway is greater than the reverse. Due to excessive prolongation of repolarization, the electrocardiogram has QT interval prolongation and T wave changes after oral administration, which can slow down the heart rate by 15~20% and prolong the PR and Q-T intervals by about 10%. It has a direct dilation effect on the coronary arteries and peripheral blood vessels. It can affect thyroid hormone metabolism. The characteristics of this product are long half-life, so the number of medications is small, the therapeutic index is large, and the antiarrhythmic spectrum is wide.

More

This product belongs to Class III antiarrhythmic drugs. The main electrophysiological effect is to prolong the action potential and effective refractory period of various myocardial tissues, which is conducive to eliminating reentrant excitation. At the same time, it has mild non-competitive α and β adrenergic receptor blocking and mild Class I and IV antiarrhythmic properties. Reduce the automaticity of the sinus node. It has no effect on the resting membrane potential and action potential height. The inhibition of forward conduction of the atrioventricular bypass pathway is greater than the reverse. Due to excessive prolongation of repolarization, the electrocardiogram has QT interval prolongation and T wave changes after oral administration, which can slow down the heart rate by 15~20% and prolong the PR and Q-T intervals by about 10%. It has a direct dilation effect on the coronary arteries and peripheral blood vessels. It can affect thyroid hormone metabolism. The characteristics of this product are long half-life, so the number of medications is small, the therapeutic index is large, and the antiarrhythmic spectrum is wide.

19774-82-4 29
Gastric flat film
This product is a compound preparation. Each tablet contains the main ingredients: 0.0125 grams of magnesium trisilicate, 0.05 grams of aluminum hydroxide, and 0.25 grams of alginate.
Name Description Content CAS NO. Registered Holders
Magnesium trisilicate

This product can neutralize gastric acid and protect the gastric mucosa with a long-lasting effect.

More

This product can neutralize gastric acid and protect the gastric mucosa with a long-lasting effect.

0.0125g 14987-04-3 11
Aluminum hydroxide

This product can neutralize gastric acid and protect the gastric mucosa with a long-lasting effect.

More

This product can neutralize gastric acid and protect the gastric mucosa with a long-lasting effect.

0.05g 21645-51-2 14
Alginic acid

This product can neutralize gastric acid and protect the gastric mucosa with a long-lasting effect.

More

This product can neutralize gastric acid and protect the gastric mucosa with a long-lasting effect.

0.25g 9005-32-7 4
Nitroglycerin solution
Name Description Content CAS NO. Registered Holders
Nitroglycerin

The main pharmacological action is to relax vascular smooth muscle. Nitroglycerin releases nitric oxide (NO), which is the same as endothelial relaxing factor, activating guanylate cyclase, increasing cyclic guanosine monophosphate (cGMP) in smooth muscle and other tissues, leading to dephosphorylation of myosin light chain, regulating the contractile state of smooth muscle, and causing vasodilation.

More

The main pharmacological action is to relax vascular smooth muscle. Nitroglycerin releases nitric oxide (NO), which is the same as endothelial relaxing factor, activating guanylate cyclase, increasing cyclic guanosine monophosphate (cGMP) in smooth muscle and other tissues, leading to dephosphorylation of myosin light chain, regulating the contractile state of smooth muscle, and causing vasodilation.

0
Ipropyram Fumarate Tablets
The main ingredient of this product is isopyram fumarate, C16H25N2O.C4H4O4.
Name Description Content CAS NO. Registered Holders
ISOPROPIRAMFUMARATE

Activation inhibits the release of pain transmitters from the lateral cord, leading to hyperactivation of intrinsic factor, which binds to the U subtype opioid receptors and inhibits serotonin and norepinephrine, thereby eliminating the pain response.

More

Activation inhibits the release of pain transmitters from the lateral cord, leading to hyperactivation of intrinsic factor, which binds to the U subtype opioid receptors and inhibits serotonin and norepinephrine, thereby eliminating the pain response.

84873-04-1 2
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.